Ácido acetil salicílico como método preventivo para la preeclampsia. una revisión integradora
Preeclampsia is a severe hypertensive disorder of pregnancy, developing around 20 weeks of gestation with elevated blood pressure and proteinuria, which can lead to life-threatening complications for both mother and fetus. The use of acetylsalicylic acid (aspirin) has been studied to prevent preecla...
Պահպանված է:
| Հիմնական հեղինակ: | |
|---|---|
| Ձևաչափ: | bachelorThesis |
| Լեզու: | spa |
| Հրապարակվել է: |
2025
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://dspace.uniandes.edu.ec/handle/123456789/19772 |
| Ցուցիչներ: |
Ավելացրեք ցուցիչ
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
|
Ավելացրեք ցուցիչ | Ամփոփում: | Preeclampsia is a severe hypertensive disorder of pregnancy, developing around 20 weeks of gestation with elevated blood pressure and proteinuria, which can lead to life-threatening complications for both mother and fetus. The use of acetylsalicylic acid (aspirin) has been studied to prevent preeclampsia. Therefore, the objective of this literature review is to describe the usefulness of acetylsalicylic acid as a preventive method for preeclampsia and to contribute to the guidance of medical personnel in the use of this drug in pregnant women at risk of preeclampsia. An integrative literature review was conducted, including original research articles, literature reviews, and full-text case studies published in indexed and peer-reviewed journals, primarily in the last five years, in Spanish and English. A total of 26 scientific articles were found, distributed as follows: 14 articles in PubMed-Medline, 4 articles in Scopus, 2 articles in Latindex, 4 articles in Web of Science, 1 article in Redalyc, and 1 article in SciELO. Based on the selection criteria, some articles were excluded: 6 articles were duplicates, 5 articles were excluded due to title issues, and 1 article was excluded because the abstract did not exactly align with the research objective. The results showed that acetylsalicylic acid can be considered a preventive method for preeclampsia. Its administration at doses of 100 to 150 mg is considerably effective in reducing the incidence of preeclampsia. This dose results in a reduction of fetal and maternal complications, making it a very safe medication for use during pregnancy. This drug should be administered before 12 weeks of gestation for optimal preeclampsia prevention. |
|---|